Literature DB >> 3011640

Subtypes of small cell carcinoma of the lung: morphometric, ultrastructural, and immunohistochemical analyses.

H Nomori, Y Shimosato, T Kodama, S Morinaga, T Nakajima, S Watanabe.   

Abstract

Fifty-three surgically resected small cell carcinomas of the lung were studied morphometrically, electron microscopically, immunohistochemically, and in terms of possible site of origin. Four subtypes of small cell carcinomas were identified: oat cell carcinoma (OAT), small cell carcinoma of the intermediate cell type (INT), combined oat cell carcinoma, and undifferentiated carcinoma of the small cell type (UCS). The latter type is presumed to be non-neuroendocrine. Morphometric analysis showed considerable overlap among OAT, INT, and UCS with respect to nuclear area, cell area, and nuclear/cytoplasmic ratio. Ultrastructurally, significantly more carcinomas categorized as OAT and INT contained neurosecretory granules than did those in the UCS category (P less than 0.01 and 0.05, respectively). Cells with tonofibrils were more frequent in UCSs than in OATs and INTs. Immunohistochemically, fewer UCSs than OATs contained cells with gastrin-releasing peptide, neuron-specific enolase, and Leu-7 (P = 0.5, P less than 0.05, and P less than 0.05, respectively). UCSs were located more frequently at the periphery of the lung than were OATs (P less than 0.01) and INTs (P = 0.06). These findings suggest that UCS may be a pathologic entity distinct from the typical neuroendocrine-type small cell carcinoma and that this subtype probably corresponds to small cell carcinoma with a "large cell component," and to very poorly differentiated adenocarcinoma and squamous cell carcinoma of the small cell type.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3011640     DOI: 10.1016/s0046-8177(86)80133-2

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  8 in total

Review 1.  Current perspectives in cancer proteomics.

Authors:  Miriam V Dwek; Sarah L Rawlings
Journal:  Mol Biotechnol       Date:  2002-10       Impact factor: 2.695

2.  Prognostic value of fluorine-18 fludeoxyglucose positron emission tomography parameters differs according to primary tumour location in small-cell lung cancer.

Authors:  Tomomi Nobashi; Sho Koyasu; Yuji Nakamoto; Takeshi Kubo; Takayoshi Ishimori; Young H Kim; Akihiko Yoshizawa; Kaori Togashi
Journal:  Br J Radiol       Date:  2016-01-12       Impact factor: 3.039

Review 3.  Neuroendocrine differentiation in lung tumours.

Authors:  M N Sheppard
Journal:  Thorax       Date:  1991-11       Impact factor: 9.139

4.  Morphometric and flow cytometric analysis of small cell undifferentiated carcinoma of the bladder.

Authors:  C E Blomjous; W Vos; N W Schipper; H J De Voogt; J P Baak; C J Meijer
Journal:  J Clin Pathol       Date:  1989-10       Impact factor: 3.411

5.  Degree of malignancy of thymic epithelial tumors in terms of nuclear DNA content and nuclear area. An analysis of 39 cases.

Authors:  H Asamura; T Nakajima; K Mukai; M Noguchi; Y Shimosato
Journal:  Am J Pathol       Date:  1988-12       Impact factor: 4.307

Review 6.  Biomarkers of response to checkpoint inhibitors beyond PD-L1 in lung cancer.

Authors:  Lynette M Sholl
Journal:  Mod Pathol       Date:  2021-10-04       Impact factor: 7.842

7.  Relationship between TA01 and TA02 polypeptides associated with lung adenocarcinoma and histocytological features.

Authors:  T Hirano; K Fujioka; B Franzèn; K Okuzawa; K Uryu; H Shibanuma; K Numata; C Konaka; Y Ebihara; M Takahashi; H Kato; G Auer
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

8.  Detection of polypeptides associated with the histopathological differentiation of primary lung carcinoma.

Authors:  T Hirano; B Franzén; K Uryu; K Okuzawa; A A Alaiya; F Vanky; L Rodrigues; Y Ebihara; H Kato; G Auer
Journal:  Br J Cancer       Date:  1995-10       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.